Key result
Lipoprotein(a) groups did not differ in CAD prevalence, though continuous Lp(a) showed an unadjusted nonlinear association with CAD-RADS severity.
Why the study?
Lipoprotein(a) is a cardiovascular risk factor, but its relationship with coronary imaging phenotypes remains incompletely characterized.
Observational (n=106)
In a referral-enriched cohort of 106 adults, continuous lipoprotein(a) demonstrated an exploratory, unadjusted nonlinear association with CAD-RADS severity on CCTA, though categorical Lp(a) (>30 mg/dL) was not significantly associated with CAD prevalence.
Answers are grounded in this paper and cite their sources.
Lp(a) assessment should not yet inform CAD-RADS reporting; leaves open validation in larger prospective cohorts.
Background: Lipoprotein(a) [Lp(a)] is a cardiovascular risk factor, but its relationship with coronary imaging phenotypes remains incompletely characterized. Methods: We performed a retrospective secondary analysis of previously collected data from 106 clinically referred adults who underwent coronary computed tomography angiography (CCTA). Analyses included a 30 mg/dL Lp(a) categorization, continuous logistic and ordinal regression, nonlinear splines, and bootstrap-based internal assessment. Clinical covariates were available only as group summaries. Results: Coronary artery disease (CAD) was present in 60.4%. CAD prevalence did not differ significantly between Lp(a) groups (odds ratio 1.82, 95% confidence interval 0.79–4.20). Continuous Lp(a) showed an unadjusted nonlinear association with Coronary Artery Disease Reporting and Data System (CAD-RADS) severity (nonlinearity p < 0.001). Coronary artery calcium (CAC) distributions were similar. The apparent area under the receiver operating characteristic curve was 0.801 (95% confidence interval 0.709–0.894). Conclusions: Lp(a) showed an exploratory nonlinear association with CCTA-defined disease in this referral-enriched cohort. Independence from confounding and clinical diagnostic utility remain unestablished.
No takes yet. Share an insight, caveat, or question.
Roșca et al. (2026) conducted an observational in Coronary artery disease (n=106). Lipoprotein(a) [Lp(a)] vs. Lp(a) < 30 mg/dL was evaluated on Coronary artery disease (CAD) presence and CAD-RADS severity (OR 1.82, 95% CI 0.79-4.20). Lipoprotein(a) groups did not differ in CAD prevalence, though continuous Lp(a) showed an unadjusted nonlinear association with CAD-RADS severity.
Synapse has enriched 10 related papers. Consider them for comparative context: